NCT07154641 Latissimus Dorsi Tendon Transfer vs. Superior Capsular Reconstruction in Massive Rotator Cuff Tears
| NCT ID | NCT07154641 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Konstantopoulio-Patission General Hospital of Nea Ionia |
| Condition | Massive Rotator Cuff Tears |
| Study Type | INTERVENTIONAL |
| Enrollment | 44 participants |
| Start Date | 2025-07-02 |
| Primary Completion | 2029-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 44 participants in total. It began in 2025-07-02 with a primary completion date of 2029-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to compare the results of two surgical operations for the treatment of massive rotator cuff tears: latissimus dorsi tendon transfer (LDT) and superior capsular reconstruction (SCR). The main question it wants to answer is which of the two operations provides better functional results, as measured by two patient-reported questionaires: the American Shoulder and Elbow Surgeons (ASES) score and the Constant-Murley score. The patients will be randomly assigned to one of two groups according to the surgery they will undergo (LDT or SCR). They will be examined clinically and asked to fill the questionaires before the surgery, at 6 weeks and at 3, 6, 12 and 24 months after surgery.
Eligibility Criteria
Inclusion Criteria: Adult patients (over 18 years old). Massive rotator cuff tear diagnosis based on shoulder MRI. - Exclusion Criteria: Advanced glenohumeral arthritis (Hamada ≥3). Deltoid dysfunction. Irrepearable subscapularis tear. Infection. Prior shoulder surgery. Shoulder stiffness. \-
Contact & Investigator
Dimitrios V Papadopoulos, MD, PhD
PRINCIPAL INVESTIGATOR
Second Department of Orthopaedics, Medical School, National and Kapodistrian University of Athens, Athens, Greece
Frequently Asked Questions
Who can join the NCT07154641 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Massive Rotator Cuff Tears. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07154641 currently recruiting?
Yes, NCT07154641 is actively recruiting participants. Contact the research team at di_papadopoulos@yahoo.gr for enrollment information.
Where is the NCT07154641 trial being conducted?
This trial is being conducted at Athens, Greece.
Who is sponsoring the NCT07154641 clinical trial?
NCT07154641 is sponsored by Konstantopoulio-Patission General Hospital of Nea Ionia. The principal investigator is Dimitrios V Papadopoulos, MD, PhD at Second Department of Orthopaedics, Medical School, National and Kapodistrian University of Athens, Athens, Greece. The trial plans to enroll 44 participants.